Screening for ovarian cancer
28 January 2020
One of the top challenges in tackling cancer is catching it early enough to carry out effective treatment. A ×î×¼µÄÁùºÏ²ÊÂÛ̳ research group is working to develop an ovarian cancer screening programme to benefit thousands more people.
A cancer screening programme is not yet available for ovarian cancer. Despite significant advances in treatment, only about 45% of women diagnosed with ovarian cancer survive for five years or more, largely because it is usually diagnosed at a late stage
A team led by Professors Usha Menon (×î×¼µÄÁùºÏ²ÊÂÛ̳ Institute for Clinical Trials and Methodology) and Ian Jacobs (previously at ×î×¼µÄÁùºÏ²ÊÂÛ̳ EGA Institute for Women’s Health) has been working on whether screening picks up the disease earlier and save lives, with a major trial with over 202,000 women and 11 years of annual screening. Women who had no screening were compared with those screened with either a vaginal ultrasound or a blood test.Â
The researchers found that the blood test picked up the cancer earlier and the screening method appears to be cost-effective.Â
Extended follow-up is now underway to establish whether this results in lives being saved. If successful, then the blood-based screening programme may be able to reduce ovarian cancer deaths by a fifth.Â
The final results of the 20-year study should be available in 2021 to help the NHS make a decision as to whether to introduce ovarian cancer screening.Â
Usha said,
“If we are able to show that a simple blood test could save lives, then it would be possible for the NHS to introduce a screening programme for ovarian cancer, similar to breast and cervical screening.
Links
- Professor Usha Menon’s academic profile
- ×î×¼µÄÁùºÏ²ÊÂÛ̳ EGA Institute for Women's Health
- ×î×¼µÄÁùºÏ²ÊÂÛ̳ Institute for Clinical Trials and Methodology
Study with us
Image credit: Illustration by Studio Imeus